Oral Anticoagulation Therapy in Atrial Fibrillation Patients with Advanced Chronic Kidney Disease: CODE-AF Registry.

Authors:
Park H; Yu HT; Kim TH; Park J; Park JK and 8 more

Journal:
Yonsei Med J

Publication Year: 2023

DOI:
10.3349/ymj.2022.0455

PMCID:
PMC9826956

PMID:
36579375

Journal Information

Full Title: Yonsei Med J

Abbreviation: Yonsei Med J

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Dr. Boyoung Joung has served as a speaker for Bayer, BMS/Pfizer, Medtronic and Daiichi-Sankyo, and has received research funds from Medtronic and Abbott. All other authors declare no competing interests. No fees were received personally."

Evidence found in paper:

"Funding acquisition: Boyoung Joung."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025